IronBridge Capital Management’s Idexx Laboratories IDXX Stock Holding History

IronBridge Capital Management’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	$7.47M	Sell	48,322 -108	-0.2%	-$14.9K	0.45%	76
2016 Q4	$5.68M	Sell	48,430 -19,292	-28%	-$2.2M	0.25%	103
2016 Q3	$7.63M	Sell	67,722 -3,650	-5%	-$385K	0.35%	86
2016 Q2	$6.63M	Sell	71,372 -60,459	-46%	-$5.19M	0.29%	97
2016 Q1	$10.3M	Sell	131,831 -3,429	-3%	-$247K	0.42%	80
2015 Q4	$9.86M	Buy	135,260 +11,836	+10%	+$844K	0.39%	84
2015 Q3	$9.16M	Sell	123,424 -4,380	-3%	-$314K	0.36%	83
2015 Q2	$8.2M	Sell	127,804 -12,240	-9%	-$847K	0.25%	101
2015 Q1	$10.8M	Sell	140,044 -5,840	-4%	-$454K	0.31%	82
2014 Q4	$10.8M	Buy	145,884 +55,400	+61%	+$3.88M	0.3%	92
2014 Q3	$5.33M	Buy	+90,484	New	+$5.72M	0.14%	147

Other funds holding IDXX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

ACM

Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

IronBridge Capital Management's IDXX Position: Q1 2017 in Review

IronBridge Capital Management reduced its Idexx Laboratories (IDXX) stake by 0.22% in Q1 2017, selling an estimated $14.9K and leaving 48,322 shares worth $7.47M. The position accounts for 0.45% of the portfolio, ranked #76.

IronBridge Capital Management first reported a position in IDXX in Q3 2014 and has held it in 11 quarters since. The position peaked at $10.8M in Q1 2015. 542 funds tracked by Wall St. Rank hold IDXX as of Q1 2017.

IronBridge Capital Management held 48,322 shares of Idexx Laboratories worth $7.47M as of Q1 2017.
IronBridge Capital Management sold 108 Idexx Laboratories shares in Q1 2017, an estimated $14.9K.
Idexx Laboratories made up 0.45% of IronBridge Capital Management's portfolio in Q1 2017, its #76 holding.
IronBridge Capital Management first reported a position in Idexx Laboratories in Q3 2014 and has held it in 11 quarters since.
IronBridge Capital Management's Idexx Laboratories position peaked at $10.8M in Q1 2015.
542 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2017.

Based on IronBridge Capital Management's 13F filing for Q1 2017, filed 10 May 2017.